mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
0.058 |
0.7 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
XMD11-85h |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.7 |